Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Özkan

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Transplantation Proceedings|April 30, 2013
Paired exchange kidney transplantation experience of TurkeyL Yücetin, S Tilif, N Keçecioğlu, et al.
Drug Development and Industrial Pharmacy|March 23, 2025
Metabolomic profiles altered by erlotinib encapsulated in poly(lactide-co-glycolide) nanoparticles in non-small cell lung cancerÇiğdem Yücel, Ozgur Esim, Nurgül K Bakırhan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registryA Özkan, E Kapiteijn, F van den Bos, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Transplantation Proceedings|April 30, 2013
Paired exchange kidney transplantation experience of TurkeyL Yücetin, S Tilif, N Keçecioğlu, et al.
Drug Development and Industrial Pharmacy|March 23, 2025
Metabolomic profiles altered by erlotinib encapsulated in poly(lactide-co-glycolide) nanoparticles in non-small cell lung cancerÇiğdem Yücel, Ozgur Esim, Nurgül K Bakırhan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registryA Özkan, E Kapiteijn, F van den Bos, et al.
Pageof 3